Read + Share
Amedeo Smart
Independent Medical Education
Esaki N, Sakoda T, Ando R, Miyai Y, et al. Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma. Oncogene 2025;44:4576-4586.PMID: 41120731
Email
LinkedIn
Privacy Policy